Revolution Medicines (RVMD) EBT Margin (2019 - 2023)

Revolution Medicines has reported EBT Margin for 5 years, with the latest figure at 21831.0% in Q4 2023.

• On a quarterly basis, EBT Margin fell 2146159.0% year-over-year to 21831.0% in Q4 2023; TTM through Sep 2024 was 76483.83%, a 7520239.0% decrease from a year earlier, with the FY2023 full-year figure at 3805.55%, down 310141.0% from the prior year.
• EBT Margin was 21831.0% for Q4 2023 at Revolution Medicines, down from 2570.55% in the prior quarter.
• The five-year high for EBT Margin was 76.95% in Q1 2019, with the low at 21831.0% in Q4 2023.
• Average EBT Margin over 5 years is 1951.41%, with a median of 386.72% recorded in 2020.
• The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 261449 bps in 2022, then slumped 2146159 bps in 2023.
• Over 5 years, EBT Margin stood at 156.92% in 2019, then plunged by 146 bps to 386.72% in 2020, then plunged by 44 bps to 556.83% in 2021, then surged by 34 bps to 369.41% in 2022, then plunged by 5810 bps to 21831.0% in 2023.
• The last three EBT Margin figures came in at 21831.0% (Q4 2023), 2570.55% (Q2 2023), and 970.89% (Q1 2023), per Business Quant data.